1. WNT signalling pathways as therapeutic targets in cancer;Anastas;Nat. Rev. Cancer,2013
2. Aravindan, N., et al., MicroRNAs in neuroblastoma tumorigenesis, therapy resistance, and disease evolution. Cancer drug resistance (Alhambra, Calif.), 2019. 2: p. 1086.
3. MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis;Cai;J. Clin. Investig.,2013
4. Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present;Casimiro;Expert Opin. Invest. Drugs,2014
5. MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer;De Chen;Oncotarget,2015